drs. G. Piersma-Wichers

Faculty of Medical Sciences

Telephone:

E-mail:

m.piersma umcg.nl

Research Portal

Publications

Effect of switching from acenocoumarol to phenprocoumon on time in therapeutic range and INR variability: A cohort study

van Miert, J. H. A., Veeger, N. J. G. M. , Ten Cate-Hoek, A. J., Piersma-Wichers, M. & Meijer, K. , 10-Jul-2020 , In: PLoS ONE. 15 , 7 , 17 p. , e0235639.

Research output: Contribution to journal › Article › Academic › peer-review

More precise dosing of acenocoumarol for better control in patients aged above 80 years, a randomised controlled pilot study

Piersma-Wichers, M. , van Miert, J. H. A., Veeger, N. J. G. M. , Kooistra, H. A. M. & Meijer, K. , Dec-2020 , In: Thrombosis Research. 196 , p. 536-538 3 p.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Quality of life after switching from well-controlled vitamin K antagonist to direct oral anticoagulant: Little to GAInN

van Miert, J. H. A., Kooistra, H. A. M. , Veeger, N. J. G. M. , Westerterp, A., Piersma-Wichers, M. & Meijer, K. , Jun-2020 , In: Thrombosis Research. 190 , p. 69-75 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

Choosing between continuing vitamin K antagonists (VKA) or switching to a direct oral anticoagulant in currently well-controlled patients on VKA for atrial fibrillation: a randomised controlled trial (GAInN)

van Miert, J. H. A., Kooistra, H. A. M. , Veeger, N. J. G. M. , Westerterp, A., Piersma-Wichers, M. & Meijer, K. , Aug-2019 , In: British Journal of Haematology. 186 , 3 , p. e21-e23 3 p.

Research output: Contribution to journal › Article › Academic › peer-review

Directe orale antistollingsmiddelen ook in Nederland een goede keus

van Miert, J., Piersma-Wichers, M. & Meijer, K. , 19-Jul-2019 , (E-pub ahead of print) In: Huisarts en Wetenschap. 1 p.

Research output: Contribution to journal › Article › Professional

Effectiveness and safety of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation

Korenstra, J., Wijtvliet, E. P. J., Veeger, N. J. G. M. , Geluk, C. A., Bartels, G. L., Posma, J. L., Piersma - Wichers, M. , Van Gelder, I. C. , Rienstra, M. & Tieleman, R. G., Sep-2016 , In: Europace. 18 , 9 , p. 1319-1327 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients

Kooistra, H. A. M. , Piersma-Wichers, M. , Kluin-Nelemans, H. C. , Veeger, N. J. G. M. & Meijer, K. , Jul-2016 , In: Circulation: Cardiovascular Quality and Outcomes. 9 , 4 , p. 388-394 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists

Kooistra, H. A. M. , Calf, A. H., Piersma - Wichers, G. , Kluin-Nelemans, H. C. , Izaks, G. J., Veeger, N. J. G. M. & Meijer, K. , Aug-2016 , In: Jama Internal Medicine. 176 , 8 , p. 1176-1183 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Impact of vitamin k antagonists (VKA) on quality of life (QOL) in a prospective cohort of 807 atrial fibrillation (AF) patients

Kooistra, H. A. , Piersma-Wichers, M. , Kluin-Nelemans, H. C. , Veeger, N. J. & Meijer, K. , Jun-2015 , In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 13 , p. 132-132 1 p.

Research output: Contribution to journal › Meeting Abstract › Academic

Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients

Kooistra, H. A. M. , Veeger, N. J. G. M. , Khorsand, N., Kluin-Nelemans, H. C. , Meijer, K. & Piersma - Wichers, M. , Apr-2015 , In: Thrombosis and Haemostasis. 113 , 4 , p. 881-890 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

All (11) publications

View full research profile